Koyfin Home > Directory > Health Care > Albireo Pharma Inc > Cash from Financing Activities

Albireo Pharma Inc Cash from Financing Activities Chart (ALBO)

Albireo Pharma Inc annual/quarterly Cash from Financing Activities from 2015 to 2020.
  • Albireo Pharma Inc Cash from Financing Activities for the quarter ending June 06, 2020 was $24m a 99.68% increase of 24m year over year
  • Albireo Pharma Inc Cash from Financing Activities for the last 12 months ending June 06, 2020 was $69m a 67.66% increase of 47m year over year
  • Albireo Pharma Inc Annual Cash from Financing Activities for 2019 was $24m a -492.16% decrease of -116m from 2018
  • Albireo Pharma Inc Annual Cash from Financing Activities for 2018 was $139m a 67.07% increase of 93m from 2017
  • Albireo Pharma Inc Annual Cash from Financing Activities for 2017 was $46m a 83.39% increase of 38m from 2016
Other Cash Flow Metrics:
  • Albireo Pharma Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $-10m a 110.98% decrease of -11m year over year
  • Albireo Pharma Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-10m a 91.45% decrease of -10m year over year
  • Albireo Pharma Inc Total Revenue for the quarter ending September 09, 2018 was $0m a 100.42% increase of 0m year over year
View Chart On Koyfin

Quarterly ALBO Cash from Financing Activities Data

06/2020$24m
03/2020$43m
12/2019$1m
09/2019$0m
06/2019$21m
03/2019$1m
12/2018$0m
09/2018$0m
06/2018$0m
03/2018$139m

Annual ALBO Cash from Financing Activities Data

2019$24m
2018$139m
2017$46m
2016$8m
2015$2m
2014$8m